In the case of bone reconstruction, when describing the contact between the tissue of the patient and the implant doctors talk about the phenomenon of osteoinduction when it reaches the stage of differentiation of the cells and the formation of preosteoblasts from the initially undifferentiated cells. Histological evidence of osteoinduction of a particular component is the formation of bone tissue in another tissue (e.g. subcutaneous) after the component is grafted to it. The production of bone tissue on the surface of the implant in immediate contact with the graft, on the other hand, is called osteoconductivity. If as a result of osteoinduction and osteoconductivity a permanent connection is formed between the tissue and the implant which will last for a long period of time, this is referred to as osteointegration (ref. 1 ). An important role in these processes is played by the surface layer of the implant.
For the reconstruction of bone tissue many materials re used, such as metals, ceramics, polymers, and also composites. There is an enormous potential in the use of polymers, which are frequently employed in reconstruction surgery of tissues and organs (refs. 2 -4) . Polymers used to replace bone losses (which for the sake of brevity we shall call bone implants) must be adequately tolerated by the patient's tissue (biocompatibility). This requirement relates both to the material in the initial state and to the products of its degradation.
Resorbable polymers are mainly useful as bone connections, which unlike metal components of this type do not have to be removed by reoperation after the correct bone growth has been obtained. Such polymers can also be used in the construction of grafts by tissue engineering methods. In this technique the polymer forms a three-dimensional scaffold of living cells of the patient, cultivated in vitro, which after implantation into the patient's tissues serve to reproduce in situ the bone tissue.
In addition to the condition of biocompatibility the ideal polymer must be characterised here by a mechanical strength sufficient to replace the mechanical function of bone, and must be resistant to radiation sterilisation and relatively easy to remould, ideally with the possibility of later modification of the shape in the operating theatre, immediately prior to implantation, so that it can be adapted to the individual needs of the patient. A critical requirement for polymers is biotolerance of the tissues after implantation and of the cells cultivated in vitro in direct contact with the material. The correct flattening of the cells in the culture, their proliferation and ultimate differentiation and maturing, and also the capacity to produce an extracellular matrix in vitro depend mainly on the chemical structure and topography of the top layer of the implant. From this arises the need to modify the surface layer of polymers for bone grafts. In the present article we have devoted particular attention to important problem; and this is a brief survey of the properties of polymers used for bone implantation and a discussion of the results of our own studies in this field.
POLYMERIC BONE IMPLANTS

Type of Polymeric Materials
Many polymers are used as biomaterials, differing in molecular weight, degree of polydispersity, glass transition temperature and main chain structure, and they can be of natural or synthetic derivation (refs. 2 -5). They can be divided up not only according to their chemical structure but also according to the type of tissue which they are to replace.
In the case of bone implants the polymers employed are chiefly those that are subject to gradual erosion (starting from the outer layers) but not to chemical degradation through the whole mass (ref. 6) , which can cause a sudden loss of mechanical properties. Gradual erosion -layer by layer -allows the real bone tissue to be formed in stages.
Detailed descriptions of the properties of polymers for bone implants can be found in numerous surveys (refs. 3, 4, 7 and 8) . In the present study we shall present a basic characterisation, particularly of those materials which have been approved for use by the FDA (Food and Drug Administration) or which have exceptional features. The basic properties and commercial names of products approved for use within the framework of procedure 510(k) (the product is similar to a product already on the market and its approval may not require clinical studies) and the PMA procedure (Premarket Approval), which may require clinical studies, can be found in the references (refs. 3, 5, 7 and 8). the copolymers poly-D,L-lactide (DLPLA), poly(D,Llactide-co-poly-L-lactide) (LDLPLA), the copolymer polyglycolide/trimethylene carbonate (PGA/TMC), the copolymer L-lactide/glycolide [LPLG -formula (V)] or poly(β-hydroxybutanoic acid) (PHB).
Homopolymeric PGA obtained from glycolide (cyclic diester of hydroxyacetic acid) has a relatively high content of crystalline phase (about 50% by mass) and a high glass transition temperature and melting point, giving rise to the formation of rigid products that suffer biodegradation in a few months. The copolymers of glycolide are characterised by rapid biodegradation, a smaller content of crystalline phase and lower transition temperatures than those of PGA.
Of the optically active forms of D and L and the racemic D,L form of lactide (cyclic diester of lactic acid) the most important for applications in implants is the L isomer. PLLA has a low crystalline phase content (about 37%), a relatively high glass transition temperature (65°C) and a long time of degradation which can reach 5 -6 years (refs. 8 and 9). Because of this latter property of PLLA, the copolymers of L-lactide do not cause significant local decrease of the pH value at the implant site (leading to acidosis and necrosis of the cells) and the occurrence of an autocatalytic effect accelerating biodegradation. Apart from the L-lactide copolymers, copolymers containing monomeric units of TMC are of great practical importance (refs. 7 and 8).
A special group of polymeric bone implants consists of the natural polymers (e.g. collagen) which are often used in the form of composites with an inorganic filler (ref. 10) . Crosslinking with the use of glutaric aldehyde permits control of the mechanical properties and the rate of resorption, and at the same time does not cause toxicity. The resulting implants have good osteoconduction properties.
Among the natural polymers used for bone implants special mention should be made of dextran hydrogels (refs. 11 -13) Using copolymers, e.g. PLLA/PCL, gives a better utilisation of the properties of the implants and a better rate of their biodegradation than when homopolymers are used. The amorphous PCL, migrating to the upper layer of the copolymer, undergoes biodegradation more rapidly than the crystalline PLLA, which remains inside the implant (ref. 17) .
Interesting alternatives to aliphatic polyesters are provided by polydoxanone (PDS), polyamino acids and pseudo-polyamino acids (polyamino acids in which the peptide units have been replaced by ester or urethane units or by carbonate units), polyanhydrides, polyorthoesters and polyurethanes, and especially polyurethanes based on oligocarbon diols (refs. 7, 18 -20) . PDS has found many applications in medicine owing to its degradation in vivo to non-toxic monomers (ref. 7) .
Polyamino acids also have a range of potential applications as biomaterials. The presence of functional groups in the side chain allows the introduction of short segments of peptides, drugs, crosslinking agents or groups modifying the physical and mechanical properties of the polymers. Polyamino acids, which are frequently employed as biomaterials, undergo biodegradation by enzymatic hydrolysis of the amide unit. During degradation of these compounds non-toxic amino acids naturally occurring in the body are released. This makes it difficult to recreate and control the process of degradation in vivo owing to the varying level of enzymatic activity, which is different in each person. A restricting factor is the fact that polymers containing three or more amino acids are recognised as antigens. The solution to this problem is provided by the use of pseudo-polyamino acids (refs. 7, 18 -20) , since the presence in the polymer chain of amide, carbonate or ester units permits a wide range of control of the rate of biodegradation; at the same time, in the case of carbonate units the products of hydrolysis contain only hydroxyl groups, which do not cause local reduction of the pH value.
Many applications, e.g. in the controlled release of drugs, involve polyanhydrides and polyorthoesters. Their degradation takes place as a result of surface erosion. In the case of polyanhydrides, depending on the degree of hydrophobicity of the particular monomer, the time of degradation can be regulated (from a few days to a year).
Porosity
Polymeric bone implants should have open pores linked in a three-dimensional network facilitating the proliferation of osteogenic cells and subsequently acting as a substrate for the extracellular matrix. The average pore size should be larger than 100 µm, and can be 150 -300 µm or even 500 -700 µm. Normally the porous structure of the implant is obtained by extraction of salts of the appropriate granule size, but in addition use is made of blowing agents such as carboxylic acids, and also foaming with gas, in the molten phase or with microwaves (ref. 21) . The porous structure of the implant prior to placing it in the bone tissue may be subsequently modified by the addition of living cells. In the case of hydrogels living cells may be found in the dispersed aqueous phase, and photocrosslinking of the hydrogel is carried out so as not to damage the living cells (ref. 11).
Mechanical Properties
Metal implants and implants made from UHMWPE (ultrahigh molecular weight polyethylene) are characterised by mechanical properties (Young's modulus, compression strength) which are greater than those of bone tissue. The bone tissue around such a (mechanically strong) implant stops functioning, becomes loosened and weak, and this can lead to serious complications. With polymeric bone implants the composition and degree of crosslinking is chosen so that their mechanical properties are as close as possible to the properties of natural bone tissue (refs. 10 and 21 -23). To reinforce the implants a filler is used, such as hydroxyapatite or calcium triphosphate in amounts of 30%. A list of fillers that may be used for making up bone losses as approved by the FDA is given in ref. 5 .
The mechanical properties of the polymer determine the method employed for preparing moulds or bone implants. The most common is injection moulding, which gives reproducible components with precisely determined measurements and mechanical properties (refs. 22 and 23) . It is still necessary to form the graft in situ according to the individual needs of the patient.
Surface Properties
A key role in adhesion and in the growth and differentiation of osteoblasts is played by the condition of the surface of the bone implant. This condition can be regarded from the viewpoint of topography, or the surface roughness, the presence of grooves/ridges and islets, or from the point of view of the chemical structure of the surface, or the presence of specialised proteins with the right sequence of amino acids, growth agents and the correct ratio of OH groups to other groups of hydrophilic and/or hydrophobic type. Interesting results of a study of the surface roughness of polystyrene/poly(4-bromostyrene) are presented in ref. 25 . This problem was examined on a nanometric scale, and islands of varying height, of the order of nanometers, were obtained. In the region of islands of 19 -35 nm they found varying adhesion of the fibroblasts to the substrate and change in the amount of proteins of the cytoskeleton. The best results for growth of fibroblasts were observed when the height of the islands was 27 nm.
Surface Modification of Polymeric Bone ImplantsBioactive Substances
The surface of bone implants is modified by agents designed to improve the adhesion of the cells to the surface. These include short amino acid sequences (RGD, RGDS, KRSR) transforming growth agent TGF-β and morphogenetic bone proteins (BMP2, BMP7) (refs. 3, 5, 26 and 27). These last take part in the differentiation of precursor cells to form osteoblasts. By the use of a printing technique (µ-contact printing) it is possible to selectively apply to the surface of the implant amino acid sequences in the form of rings of diameter 10 -200 µm (ref. 27 ). This method makes it possible to achieve adhesion of cells of a particular type on a selected region of the surface of the implant, e.g. fibroblasts and osteoblasts (sequence RGDS) or only osteoblasts (sequence KRSR), and also protection of fragments of the surface against adhesion (surface with antiadhesive octadecyltrichlorosilane).
The surfaces of biomaterials can also be modified using glycoproteins such as fibronectin, collagen, heparin or agrecan. These are substances containing sites capable of attaching components occurring in the extracellular matrix (ECM).
Another problem is to ensure that the surfaces of implants 
THE AUTHORS' OWN STUDIES
As we have already mentioned, a polymeric bone implant employed to replace bone losses has to fulfil a number of biological and physicochemical requirements. It is hard to imagine that all of these requirements could be met by one material, but they could be met by a multi-layer system made from different types of materials. One of the basic conditions that the bone implant has to meet is the correct structure and composition of the surface layer coming directly in contact with the living cells.
The aim of the present study was to assess the suitability of various types of biomaterials used as a substrate for the growth and differentiation of bone cells.
Materials
The substrates were made from the following substances:
• hydrophobic -octadecyltrichlorosilane (Aldrich), poly(dimethylsiloxane) (Petrarch Systems), trimethoxyvinylsilane (Petrarch Systems);
• hydrophilic -poly(acrylic acid) PAA, made by Fluka AG), poly(ethylene oxides) with molecular weights of 1000, 20,000 and 5,000,000 (Loba Chemie, BDH Chemicals Ltd., Ferark Berlin), isotactic poly(propylene oxide) (M = 700) and poly(ε-caprolactone) with molecular weights of 1700 and 1100 (synthesised by J. Lewinski, Chemical Division, Warsaw Polytechnic), poly(2-hydroxyethylene methacrylate) (Aldrich) and poly(N-isopropylacrylamide) (Aldrich), and polyurethanes (made by a collaboration of the Chemical Division of Warsaw Polytechnic and the Institute of Industrial Chemistry in Warsaw);
• dextran (Pharmacia Fine Chemicals AB) and mixtures of this with PAA, Ca(NO 3 ) 2 and also with drugs.
On the surfaces we also applied proteins -fibronectin (Biochrom KG, Sigma), animal albumin (Sigma), human albumin (Biomed, Warsaw) and collagen (Henkel) and also phospholipids -lecithin (Bauer) and 1-palmitoylolisolecithin (Koch-Light Lab.).
We also prepared surfaces with alternating hybrid multilayers built up from systems with PAA/bentonite (Vanderbilt), PAA/bemite (Condea Vista Company) and PAA/hydroxyapatite (Institute of Glass and Ceramics in Warsaw).
The following solvents were used: distilled water, hexane, methanol, and methylene chloride (Chemical Reagents Company, Lublin).
Equipment
The studies were carried out using standard 96-unit vessels made from polystyrene for cellular cultures, TCPS (Tissue Culture PS) made by Dow Corning. The polystyrene used for the vessel was suitably prepared by the manufacturer to improve the adhesion of the cells; this material was the reference in the studies. The general method of procedure is shown in block A. It is in accordance with similar methods currently employed in studies of this type (refs. 34 -37).
Method of Preparation of the Substrates
A tray of TCPS comprises 8 rows and 12 columns of units. Into each of these we introduced 50 µl of solution. The outer columns were disregarded for the further studies, and the application of each type of substrate in one column was repeated six times. No substrate was applied in column 2 of each TCPS tray, and this served as a reference column. C9olumn No. 3, also without substrate, was irradiated with UV radiation (λ = 365 nm), similarly to all the following columns; this was the control column. The next column was subjected to the action of the solvent itself to determine its effect on the bone cells. In the following units we evaporated the solutions of the studied substances forming the substrates (room temperature, 24 h).
We carried out 11 series of measurements as follows, divided up according to the type of substrate: The coupling agent γ-APS for the polyelectrolyte multilayer was found to be toxic with regard to the cells; for this reason we studied series No. VIII in addition to III.
Cell culture
On the modified TCPS substrates we placed a culture of human cells isolated from the bone tissue. The culture was grown in an incubator at a constant temperature of 37°C at moisture level of 96% and in the presence of 5% CO 2 for 1 week. The culture medium was a solution of DMEM Dulbeco's Modified Eagle Medium) containing an additional 10% of fetal bovine serum (FBS), 2 mM of L-glutamine and 1% of antibiotic.
For this purpose on flat surfaces of PS we poured out appropriate amounts of the same solutions of the substances (to obtain an identical surface concentration) and evaporated them off under previously determined conditions.
Study Methods
Using goniometry we determined the contact angles (CA) of the substrates formed on the PS trays. The measurements were carried out before and after the radiation sterilisation. The wetting liquid was water or a solution of DMEM.
The cell morphology was observed through a Nikon TS 100 optical microscope. In order to evaluate the average size of cell populations grown on the applied substrates the cells were coloured with crystalline violet, after which we determined the optical density using a Multiscan RC spectrophotometer (wavelength λ = 540 nm).
The XTT test is an in vivo test used for determining the activity of succinate dehydrogenase (enzyme found in the mitochondria of living cells). The compound XTT (internal salt of 2,3-bis(2-methoxy-4-nitro-5-sulphophenyl)-2H-tetrazole-5-carboxyanilide) is the substrate in the reaction taking place under the effect of succinate dehydrogenase, as a result of which there are formed coloured water-soluble formazanes (ref. 36) . The results of the test were read off from the ELISA plate reader used in the tests (wavelength λ = 450 nm, "Sigma X 425").
The ALP test, or measurement of the activity of alkaline phosphatase (the enzyme formed by the bone cells) was conducted using a system of "Sigma" No. 245 -500. The alkaline phosphatase is catalysed by hydrolysis of p-bitrophenyl phosphate, as a result of which p-nitrophenol is formed. This is a coloured product which can be determined by spectrophotometry (wavelength λ = 450 nm).
Discussion of Results
The best results were obtained in the case of surfaces with dextran and its systems (series X), and hence the results of investigations of these surfaces will now be discussed. The surfaces of dextran, especially dextran with the addition of PAA, have a strongly hydrophilic character (value of contact angle < 45° - Figure 1) . It was established that after the process of radiation sterilisation (columns No.2) the CA values increase, but the surfaces subsequently retain a strongly hydrophilic character (the CA values do not exceed 40°). Similar values for the contact angle are obtained with water.
The values of the XTT test in the region from about 70% to 100% in relation to the control sample (surface A, Figure 2 ) of series X point to a high survival rate of the cells cultivated on this surface. The highest survival rates in this series were obtained for the surface of dextran + 0.003 mol. % Ca(NO 3 ) 2 (surface F) and dextran + PAA + 0.003 mol. % of Ca(NO 3 ) 2 (surface I). In the case of the surface with only dextran (surface D) the XTT test reached a value of 83.4%.
Also the ALP tests (Figure 3) confirm the good properties of the substrates with dextran. The best results (considerably better than the control sample A) are obtained with a surface of dextran + PAA (surface E) and dextran + Ca(NO 3 ), both when we used 0.003 mol. % and 0.01 mol. % of the salt (surfaces F and H respectively).
The results presented for both sets of tests, the XTT and the ALP, thus lead to the conclusion that the survival rate of bone cells on the surfaces of dextran + Ca(NO 3 ) 2 and dextran + PAA is at least the same or greater than in the case of the standard TCPS surface.
The other types of surfaces studied (the other series) did not give such good results as dextran. The worst results of the XTT and ALP tests were found with the surfaces rendered hydrophobic by polysiloxanes (series) and in the case when methylene chloride was used as the solvent (series II), since the latter had a toxic effect on the cells. Additionally we found that the polysiloxane substrates may be utilised for the controlled protection of fragments of the surface against precipitation of the cells. The results of studies of the surfaces modified by biocompatible polymers (series IX) were similar to those obtained from assessment of the control cell culture.
We also tried to find a correlation between the value of CA and the results of the cell culture (XTT and ALP tests). It was found that the cells did not adhere either to a substrate with strongly hydrophobic properties (CA >80°) or to one with a strongly hydrophilic character (CA < 15°). However, we did not observe this as a general rule for all of the types of substrates studied. An exception was the hydrophilic surface of PAA/bentonite, to which the cells adhered (ref. 39) and where increase in the number of polyelectrophilic multilayers changed the character of the surface to hydrophilic; at the same time there was a considerable decrease in the values of the XTT and ALP tests. Then the surfaces modified with collagen also exhibit a strongly hydrophilic character (CA < 15°), and the results of the XTT and ALP tests of such surfaces are very good, and are ion a level with the control cell culture. Thus it may be affirmed that the hydrophilic or hydrophobic character of a surface is neither the only nor a sufficient criterion for assessing the right adhesion of cells to a substrate.
CONCLUSIONS
The method proposed made it possible to evaluate the quality of a surface with regard to its capacity for adhesion of bone tissues. This allowed us to characterise the substrate for further investigations as supports for bone cells. At the present stage of the investigations it seems that the most promising are hydrophilic thin layers obtained from dextran with the addition of PAA and calcium salt.
